BTAI Competitors & Alternatives

Compare BioXcel Therapeutics Inc with similar stocks in the same industry

Drug Manufacturers - Specialty & Generic

BTAI

Main Stock
$1.22
Tradestie Score
58
Market Cap
$50.49M
Revenue Growth
-0.3%
Analyst Upside
+1047.5%

Top Competitors

49 stocks in Drug Manufacturers - Specialty & Generic
Company Price Market Cap P/E Score Action
AQST Aquestive Therapeutics, Inc. Common Stock
$4.32
$711.32M - 65 Compare
ESPR Esperion Therapeutics, Inc.
$3.14
$584.71M - 57 Compare
ETON Eton Pharmaceutcials, Inc. Common Stock
$29.65
$543.32M - 60 Compare
CGC Canopy Growth Corporation Common Shares
$1.11
$430.55M - 54 Compare
ALLO Allogene Therapeutics, Inc. Common Stock
$2.28
$275.13M - 50 Compare
IRWD Ironwood Pharmaceuticals, Inc. - Class A
$4.22
$237.15M 6.7 53 Compare
BIOA BioAge Labs, Inc. Common Stock
$17.99
$212.23M - 54 Compare
ATRA Atara Biotherapeutics, Inc
$8.34
$101.48M 3.9 63 Compare
KPTI Karyopharm Therapeutics Inc.
$8.64
$53.85M - 61 Compare
KYNB KYNB
$6.95
- - 61 Compare

Data updated: May 08, 2026 | Industry: Drug Manufacturers - Specialty & Generic (SIC 2834)

49 stocks in this industry